Dentsply Sirona

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell XRAY and other ETFs, options, and stocks.

About XRAY

Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. 

CEO
Daniel T. Scavilla
CEODaniel T. Scavilla
Employees
14,000
Employees14,000
Headquarters
Charlotte, North Carolina
HeadquartersCharlotte, North Carolina
Founded
1899
Founded1899
Employees
14,000
Employees14,000

XRAY Key Statistics

Market cap
2.31B
Market cap2.31B
Price-Earnings ratio
-3.85
Price-Earnings ratio-3.85
Dividend yield
5.55%
Dividend yield5.55%
Average volume
5.90M
Average volume5.90M
High today
$12.37
High today$12.37
Low today
$11.25
Low today$11.25
Open price
$11.86
Open price$11.86
Volume
5.25M
Volume5.25M
52 Week high
$17.18
52 Week high$17.18
52 Week low
$9.85
52 Week low$9.85

Stock Snapshot

With a market cap of 2.31B, Dentsply Sirona(XRAY) trades at $11.65. The stock has a price-to-earnings ratio of -3.85 and currently yields dividends of 5.5%.

On 2026-03-14, Dentsply Sirona(XRAY) stock traded between a low of $11.25 and a high of $12.37. Shares are currently priced at $11.65, which is +3.6% above the low and -5.8% below the high.

The Dentsply Sirona(XRAY)'s current trading volume is 5.25M, compared to an average daily volume of 5.9M.

In the last year, Dentsply Sirona(XRAY) shares hit a 52-week high of $17.18 and a 52-week low of $9.85.

In the last year, Dentsply Sirona(XRAY) shares hit a 52-week high of $17.18 and a 52-week low of $9.85.

XRAY News

TipRanks 5d
Insiders Double Down on DENTSPLY SIRONA in Bold Buying Spree

New insider activity at DENTSPLY SIRONA ( (XRAY) ) has taken place on March 9, 2026. DENTSPLY SIRONA has seen notable insider buying activity, with Director Gr...

Simply Wall St 5d
A Look At Dentsply Sirona Valuation After Earnings Miss And Softer 2026 Outlook

DENTSPLY SIRONA (XRAY) shares have been in focus after quarterly results that combined higher fourth quarter sales and a smaller net loss with an earnings miss,...

A Look At Dentsply Sirona Valuation After Earnings Miss And Softer 2026 Outlook
Nasdaq 5d
Dentsply Sirona: First-ever Dental Dedicated MRI System Validated In Trial, Cleared By FDA

(RTTNews) - Dentsply Sirona (XRAY) and Siemens Healthineers (SHL.DE) announced that the dental-dedicated ddMRI system - MAGNETOM Free.Max Dental Edition - has r...

Dentsply Sirona: First-ever Dental Dedicated MRI System Validated In Trial, Cleared By FDA

Analyst ratings

72%

of 18 ratings
Buy
22.2%
Hold
72.2%
Sell
5.6%

More XRAY News

TipRanks 5d
Dentsply Sirona, Siemens Healthineers share findings from trial of MRI system

Dentsply Sirona (XRAY) and Siemens Healthineers (SMMNY) share key findings from the clinical trial for validation of their dental-dedicated MRI system. In addit...

Simply Wall St 7d
Dentsply Sirona Broadens US Reach As Board Refresh Shapes Growth Story

Dentsply Sirona (NasdaqGS:XRAY) expanded its partnership with Burkhart Dental Supply to distribute its full technology portfolio across the US. The company als...

Dentsply Sirona Broadens US Reach As Board Refresh Shapes Growth Story

People also own

Based on the portfolios of people who own XRAY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.